Rapid progression of prostate cancer in men with a BRCA2 mutation. - Wikidata - awgldk - TriplyDB

Rapid progression of prostate cancer in men with a BRCA2 mutation.

Rapid progression of prostate cancer in men with a BRCA2 mutation.

http://www.wikidata.org/entity/Q36785963

about

Brca2 and Trp53 deficiency cooperate in the progression of mouse prostate tumourigenesis Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer.Cancer biomarker discovery: the entropic hallmark.Personalized prostate cancer screening among men with high risk genetic predisposition- study protocol for a prospective cohort study.Direct cooperation between androgen receptor and E2F1 reveals a common regulation mechanism for androgen-responsive genes in prostate cells.Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis.Differing clinical impact of BRCA1 and BRCA2 mutations in serous ovarian cancer.Skp2 overexpression is associated with loss of BRCA2 protein in human prostate cancer.The therapeutic ratio is preserved for radiotherapy or cisplatin treatment in BRCA2-mutated prostate cancers Cancer worry among Norwegian male BRCA1/2 mutation carriers.BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients.The role of BRCA1 and BRCA2 mutations in prostate, pancreatic and stomach cancers Interest of individuals from BRCA families to participate in research studies focused on male BRCA carriers An inherited NBN mutation is associated with poor prognosis prostate cancer Determining the frequency of pathogenic germline variants from exome sequencing in patients with castrate-resistant prostate cancer.Genetic evaluation and testing for hereditary forms of cancer in the era of next-generation sequencing.Biallelic BRCA2 Mutations Shape the Somatic Mutational Landscape of Aggressive Prostate Tumors A personalised approach to prostate cancer screening based on genotyping of risk founder alleles Germline BRCA mutations denote a clinicopathologic subset of prostate cancer.The role of BRCA1 and BRCA2 in prostate cancer.Germline genetic profiling in prostate cancer: latest developments and potential clinical applications.Familial prostate cancer: the damage done and lessons learnt.New insights into the prevention and treatment of familial breast cancer.BRCA1 and BRCA2 - update and implications on the genetics of breast cancer: a clinical perspective.The genetic epidemiology of prostate cancer and its clinical implications.An arranged marriage for precision medicine: hypoxia and genomic assays in localized prostate cancer radiotherapy.Nucleic acid-based tissue biomarkers of urologic malignancies.Hereditary breast cancer syndromes and genetic testing.Investigating BRCA Mutations: A Breakthrough in Precision Medicine of Castration-Resistant Prostate Cancer.PTEN deletion in prostate cancer cells does not associate with loss of RAD51 function: implications for radiotherapy and chemotherapy.The presence of prostate cancer at biopsy is predicted by a number of genetic variants.The impact of a BRCA2 mutation on mortality from screen-detected prostate cancer.Urologists' and GPs' knowledge of hereditary prostate cancer is suboptimal for prostate cancer counseling: a nation-wide survey in The Netherlands.Sustained Complete Response to Cytotoxic Therapy and the PARP Inhibitor Veliparib in Metastatic Castration-Resistant Prostate Cancer - A Case Report.Update on Screening for Urological Malignancies.Genetic variants associated with predisposition to prostate cancer and potential clinical implications.NSGC practice guideline: risk assessment and genetic counseling for hereditary breast and ovarian cancer.Germline BRCA mutation in male carriers-ripe for precision oncology?Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study.Within-Gender Differences in Medical Decision Making Among Male Carriers of the BRCA Genetic Mutation for Hereditary Breast Cancer.

P2860

Q27347240-B2EB2AAF-C3FF-48C2-ACF0-4C6727ED69D4 Q27852185-FD268463-D8D4-474F-990F-1660B42BCE08 Q30496149-37F632D4-7A0D-4190-9108-AECB97FE6526 Q30597063-D4EB2310-87B2-4570-95FA-88B96EA8103F Q33636324-4C6A1C1E-6C2E-4FAB-904F-69FC6EADC754 Q34168304-A06DB7D6-A5B1-4AC4-BA18-C0ED78DC3E42 Q34305493-27688D67-E15F-4E00-8232-831ED2919174 Q34838226-382E6551-F34B-4AF2-B51D-4209247B313C Q35014762-450D7EA1-B296-4D1A-960F-A49FB78C132A Q35219186-1667D81C-C04B-4A6A-A5B4-0B50A774FD7D Q35527158-0BA123E6-F7DC-4FFB-981C-5F263D9CF147 Q35906685-7FAC7567-8D94-4E29-A0DB-2CAA9987A9BB Q35907075-5262C5EE-7012-4050-8B79-F29B8C9E8E97 Q36594121-0C8ACC3C-D944-4A6A-ACFF-8A879725A118 Q36818918-93952A41-7FA3-458B-B808-9F0978F7A89D Q36849670-198E5A34-3CCA-478E-B258-273E40923827 Q36891144-6A38D46F-09AF-451B-8A08-DBD2DDF08C46 Q36959139-85A10F7D-B6D1-4B38-8D3A-093341A931B5 Q37019841-2F2177C5-446B-47BA-91F2-2B140B8A6A79 Q37037789-FE0C03E4-688E-4C96-9487-DBDC1E78B081 Q37474516-EC2B00DA-58E0-492D-8DAB-CE7E849F3498 Q37553869-852675A0-1A93-4520-829A-682BCF189C2D Q37845305-DFF47A62-7729-49DD-B57B-87C6B33A45FD Q38151730-0190C5C4-53A0-4D62-8B9E-52ADC44B4D3A Q38168060-C5A4800F-8E77-4C1F-A355-B3D32A65D0E9 Q38192714-42F13ABF-336F-4391-99A8-A53610B3FF39 Q38216131-66E74016-3A52-4E83-A966-F077BDF186A7 Q38266306-2AB02159-CC0F-42F1-8347-7697EBB468F7 Q38893354-318ECBE4-A4D9-44C2-980F-8FD751AF1AC1 Q39437808-43BB92EA-8C17-4501-95DF-F5BB50624DCC Q40137412-05EA2258-6036-4A06-8496-A2ADD7FF5CBB Q40213120-B95814E3-7CFF-46B1-A6BD-125C39200365 Q42182516-239067C8-BD26-40A8-986A-0F70B3F6460D Q42370398-F271BAA6-F422-4388-947D-D86B1399D1E7 Q42649779-1151B01A-7DCC-4D55-A7C5-5244287DBCEA Q43415543-7254806B-F264-4636-B0F0-9254C8E5FF12 Q46782906-D1DF19A4-AD6A-4A55-BB09-29D87B74CE4E Q46798905-42842A6B-26CF-46AE-96ED-B57C8E373DCB Q46935108-3DF2DA2A-720A-4769-AE14-E3BE6BE3B6B9 Q47138471-493F1AAE-A7B4-434B-AE2B-FA40AFB8F344

P2860

Rapid progression of prostate cancer in men with a BRCA2 mutation.

http://www.wikidata.org/entity/Q36785963

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Rapid progression of prostate cancer in men with a BRCA2 mutation.

@en

type

label

Rapid progression of prostate cancer in men with a BRCA2 mutation.

@en

prefLabel

Rapid progression of prostate cancer in men with a BRCA2 mutation.

@en

P1433

Q36785963-6694FA23-0977-40A7-B127-829DDCDE333A

P1476

Q36785963-5B9CCAE1-EA77-4D7C-8C21-0C2B095ABC60

P2093

Q36785963-076842F3-3CAA-4CC3-A447-2D389A42935A

Q36785963-0CC755CC-2ED4-40FC-A1C3-A25DBDB44FA9

Q36785963-12B0937E-16BC-4CB8-A70C-9C674B7FFB0D

Q36785963-15FAE8B1-1805-4958-86BB-BBDFECBBE2D2

Q36785963-1E829C94-26DF-4DD2-B227-0B29E0A42459

Q36785963-2214165B-B246-4E86-84C9-B227AA529AA2

Q36785963-2A62D197-E5A0-4C68-9D8A-E151ABA75447

Q36785963-2ED08D2C-A1A9-4BC6-B59D-6299B0986E03

Q36785963-2F349026-8C2B-4E22-A74A-9EE74E7D5256

Q36785963-3F2970E5-B616-476D-AB91-FCBEDAEE84A0

P2860

Q36785963-2D85DE33-1AD0-49E1-963C-260EC15528C6

Q36785963-3B8F512C-6C22-4176-8802-EC4BBB3B3DE5

Q36785963-569DB4C7-815C-4741-B733-9BCEF16A8776

Q36785963-58DB6745-D3AD-4107-913B-871C9E89C6F3

Q36785963-68C933C4-7186-433B-A490-7BBBDF0AD504

Q36785963-97514134-1DA6-4AB7-B512-6EED83185671

Q36785963-97ADA44C-2D0E-4BF6-BAE1-4C7FB0FDD0B8

Q36785963-D0D0F3A6-FE79-4EA8-96AE-C6E086B878BD

Q36785963-E52827CB-A632-4230-836A-AFF0737CA94F

Q36785963-EDEB0ABB-B1FF-4CCC-B979-D52E8FA2EC59

P2888

Q36785963-07F175BA-9C49-4963-B532-BED09DA561F5

P304

Q36785963-EA8BFFA8-1F4A-4AB1-A55A-9B08EE0415AF

P31

Q36785963-A328A190-27D9-4664-B072-C85C03B8A41F

P356

Q36785963-DF4D440E-387C-4B83-8490-74388506B78C

P407

Q36785963-5DA378F5-01F3-4F77-BAEC-3E0F795A0222

P433

Q36785963-1E74AFB1-DCD5-4080-98D4-D8F236EDC5EB

P478

Q36785963-F7851DAB-E121-4357-AA3E-100E0BC84B60

P50

Q36785963-130984C2-0076-433A-9B99-FD553C74DA86

Q36785963-44B44F89-83E6-4D7F-AD79-AD1A332ADC41

Q36785963-53D3A01F-CA58-4D2E-9026-56DD89E6FA7E

Q36785963-5685C3C2-404A-43BC-89CF-9A16572A9F45

Q36785963-6F8A0E98-64C8-4755-876F-EA5DACFC9152

Q36785963-CEB1D87A-738F-41C8-A2BB-13A67060939B

Q36785963-E89F9169-6EC2-4A9B-8A30-FA8E71E2D940

Q36785963-F03E0265-F13E-429E-97E4-EACF4318331B

Q36785963-F981851D-9F3D-4880-9953-F405F3AEF96C

Q36785963-FCF01F08-6275-4BF0-B1EE-0B7D32451884

P577

Q36785963-E86CD3BE-1B3B-4E0F-8609-6B8BBFF64C8A

P5875

Q36785963-4D8BB558-8D84-42F6-957B-568556D7ABC7

P698

Q36785963-521D8BFB-5CBF-493B-890C-890A7E931A1A

P932

Q36785963-F3DF2DA7-AB3A-44BB-923F-AB91B043B661

P356

P1433

British Journal of Cancer

P1476

Rapid progression of prostate cancer in men with a BRCA2 mutation.

@en

P2093

A Poll

http://www.w3.org/2001/XMLSchema#string

A Tulman

http://www.w3.org/2001/XMLSchema#string

Andrea Eisen

http://www.w3.org/2001/XMLSchema#string

Barbara Pasini

http://www.w3.org/2001/XMLSchema#string

Beth Karlan

http://www.w3.org/2001/XMLSchema#string

Charmaine Kim-Sing

http://www.w3.org/2001/XMLSchema#string

Christina Bellati

http://www.w3.org/2001/XMLSchema#string

Christine Maugard

http://www.w3.org/2001/XMLSchema#string

Dawna Gilchrist

http://www.w3.org/2001/XMLSchema#string

Douglas Horsman

http://www.w3.org/2001/XMLSchema#string

P2860

Radical prostatectomy versus watchful waiting in early prostate cancer.

Cancer risks in BRCA2 mutation carriers.

Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature.

Rare germline mutations in the BRCA2 gene are associated with early-onset prostate cancer.

Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype

Loss of BRCA2 promotes prostate cancer cell invasion through up-regulation of matrix metalloproteinase-9.

Cancer risks in BRCA2 families: estimates for sites other than breast and ovary.

BRCA1 mutations and prostate cancer in Poland.

BRCA mutations and risk of prostate cancer in Ashkenazi Jews.

Prostate Cancer Progression and Survival in BRCA2 Mutation Carriers

P2888

P304

371-374

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6604453

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

99

http://www.w3.org/2001/XMLSchema#string

P50

Dominique Stoppa-Lyonnet

William D Foulkes

Steven A. Narod

Siranoush Manoukian

Susan M Domchek

Fergus J. Couch

Susan L Neuhausen

Jeffrey N Weitzel

Olufunmilayo Olopade

Claudine Isaacs

P577

2008-06-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5278220

http://www.w3.org/2001/XMLSchema#string

P698

18577985

http://www.w3.org/2001/XMLSchema#string

P932

2480973

http://www.w3.org/2001/XMLSchema#string